127 related articles for article (PubMed ID: 38247337)
1. Treatment for SMARCB1 (INI-1) deficient sinonasal tumor: a single-institution study.
Wang T; Wang J; Tang T; Wang L; Li Y; Song X
Neoplasma; 2023 Dec; 70(6):804-810. PubMed ID: 38247337
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the diagnosis and treatment of patients with SMARCB1 (INI-1)-deficient sinonasal carcinoma].
Wang LW; Wang R; Fang JG; Zhong LZ; Hou HZ; Ma L; Feng SZ; He CS; Wang L; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 57(7):848-853. PubMed ID: 35866278
[No Abstract] [Full Text] [Related]
3. Clinical Diagnosis and Treatment Analyses on SMARCB1 (Integrase Interactor 1)-Deficient Sinonasal Carcinoma: Case Series with Systematic Review of the Literature.
Wang R; Wang L; Fang J; Zhong Q; Hou L; Ma H; Feng L; He S; Wang C; Zhang L
World Neurosurg; 2022 May; 161():e229-e243. PubMed ID: 35123020
[TBL] [Abstract][Full Text] [Related]
4. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma.
Contrera KJ; Shakibai N; Su SY; Gule-Monroe MK; Roberts D; Brahimaj B; Williams MD; Ferrarotto R; Phan J; Gunn B; Raza S; DeMonte F; Hanna EY
Otolaryngol Head Neck Surg; 2023 Aug; 169(2):435-440. PubMed ID: 36856048
[TBL] [Abstract][Full Text] [Related]
5. SMARCB1-Deficient Sinonasal Carcinoma: Systematic Review and Case Report.
Parsel SM; Jawad BA; McCoul ED
World Neurosurg; 2020 Apr; 136():305-310. PubMed ID: 32001406
[TBL] [Abstract][Full Text] [Related]
6. SMARCB1 (INI-1) - Deficient sinonasal carcinoma: Report of two cases.
Vasudevan G; Srinivas SP; Nayal B; Jayaprakash P; Ramaswamy B
Indian J Pathol Microbiol; 2023; 66(2):352-355. PubMed ID: 37077082
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma].
Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
[No Abstract] [Full Text] [Related]
8. Immunotherapy in SMARCB1 (INI-1)-deficient sinonasal carcinoma: Two case reports.
Zhang L; Gao AX; He YL; Xu MJ; Lu HJ
World J Clin Cases; 2023 Nov; 11(32):7911-7919. PubMed ID: 38073679
[TBL] [Abstract][Full Text] [Related]
9. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and pathological analysis of 2 cases of
Chen ZW; Fang SG; Ren JQ; Qian LJ; Shi HQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):400-402. PubMed ID: 32306640
[TBL] [Abstract][Full Text] [Related]
11. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma.
Allard FD; Bell D; Stelow EB
Cancer Cytopathol; 2018 Aug; 126(8):567-574. PubMed ID: 29797680
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in late elderly (aged 75 or older) patients with paranasal sinus carcinoma: a single institution experience.
Doi H; Kitajima K; Tanooka M; Terada T; Noguchi K; Takada Y; Fujiwara M; Ishikura R; Kamikonya N; Hirota S
Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4485-4492. PubMed ID: 27314860
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.
Abdelmeguid AS; Teeramatwanich W; Roberts DB; Amit M; Ferraroto R; Glisson BS; Kupferman ME; Su SY; Phan J; Garden AS; Raza SM; DeMonte F; Hanna EY
Cancer; 2021 Jun; 127(11):1788-1795. PubMed ID: 33567468
[TBL] [Abstract][Full Text] [Related]
14. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
McHugh KE; Policarpio-Nicolas MLC
Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
[TBL] [Abstract][Full Text] [Related]
15. Retrospective Analysis of Induction Chemotherapy plus Concurrent Chemoradiotherapy under Intensity-Modulated Radiotherapy Mode for Locally Advanced Nasopharyngeal Carcinoma.
Liao K; Tao HY; Zhan ZJ; Qiu WZ; Zheng RH
Oncol Res Treat; 2021; 44(11):602-612. PubMed ID: 34601467
[TBL] [Abstract][Full Text] [Related]
16. SMARC-B1 deficient sinonasal carcinoma metastasis to the brain with next generation sequencing data: a case report of perineural invasion progressing to leptomeningeal invasion.
Gomez-Acevedo H; Patterson JD; Sardar S; Gokden M; Das BC; Ussery DW; Rodriguez A
BMC Cancer; 2019 Aug; 19(1):827. PubMed ID: 31438887
[TBL] [Abstract][Full Text] [Related]
17. Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas.
Dogan S; Cotzia P; Ptashkin RN; Nanjangud GJ; Xu B; Momeni Boroujeni A; Cohen MA; Pfister DG; Prasad ML; Antonescu CR; Chen Y; Gounder MM
Hum Pathol; 2020 Oct; 104():105-116. PubMed ID: 32818509
[TBL] [Abstract][Full Text] [Related]
18. SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Case Report and Literature Review.
Yang H; Zhou L; Zhong G; Li X; Wang Y
Ear Nose Throat J; 2022 May; ():1455613221082622. PubMed ID: 35603532
[No Abstract] [Full Text] [Related]
19. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.
Bishop JA; Antonescu CR; Westra WH
Am J Surg Pathol; 2014 Sep; 38(9):1282-9. PubMed ID: 25007146
[TBL] [Abstract][Full Text] [Related]
20. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
Kezlarian BE; Lin O; Dogan S
J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]